logo

For the Inventor, By the Inventor

London, Canada

Viron Therapeutics, Inc.


USPTO Granted Patents = 15

% Expired Patents = 66.7


Trademarks = 2

Forward Citations = 73

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Alexandra Lucas (11 out of 13 patents)

silverMedal Grant McFadden (9 out of 15 patents)

bronzeMedal D Grant McFadden (4 out of 5 patents)

4.  Karim Essani (3 out of 4 patents)

5.  Xing Li (3 out of 5 patents)

6.  Robert Zhong (2 out of 2 patents)

7.  Alexandra Rose Lucas (1 out of 5 patents)

8.  Z Robert Zhong (1 out of 1 patent)

9.  D Grant Mcfadden (0 patent)

10.  Grant D Mcfadden (0 patent)


15 patents:

1. 8268331 - Nucleic acid molecules and polypeptides for immune modulation (2012-09-18),
2. 8227569 - Immunomodulatory protein and useful embodiments thereof (2012-07-24),
3. 7906483 - Method for treating transplant rejection (2011-03-15),
4. 7745396 - Use of SERP-1 as an antiplatelet agent (2010-06-29),
5. 7718368 - Immunomodulatory protein and useful embodiments thereof (2010-05-18),
6. 7585507 - Nucleic acid molecules and polypeptides for immune modulation (2009-09-08),
7. 7514405 - Methods for treating transplant rejection (2009-04-07),
8. 7419670 - Method of treating arthritis with SERP-1 and an immunosuppressant (2008-09-02),
9. 7285530 - Use of SERP-1 as an antiplatelet agent (2007-10-23),
10. 7101559 - Immunomodulatory protein and useful embodiments thereof (2006-09-05),
11. 6894155 - Nucleic acid molecules and polypeptides for immune modulation (2005-05-17),
12. 6589933 - Myxoma chemokine binding protein (2003-07-08),
13. 6495515 - Chemokine binding protein and methods of use therefor (2002-12-17),
14. 5939525 - Methods of treating inflammation and compositions therefor (1999-08-17),
15. 5917014 - Methods of treating inflammation and compositions therefor (1999-06-29),
Company Overview
Viron Therapeutics, Inc. is a biotechnology company based in London, Canada, focused on developing innovative therapies for various medical conditions. The organization specializes in harnessing advanced technologies to create novel treatments, particularly in the fields of drug discovery and development. With a commitment to addressing unmet medical needs, Viron Therapeutics aims to leverage its expertise to improve patient outcomes through cutting-edge research and development initiatives.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

15 Patents

#13 in London

#983 in Canada

#39,921 in the World

London, CA
London, Canada

Viron Therapeutics, Inc.

Forward Citations = 73

8 inventors:

goldMedal Alexandra Lucas (11 out of 13 patents)

silverMedal Grant McFadden (9 out of 15 patents)

bronzeMedal D Grant McFadden (4 out of 5 patents)

4.  Karim Essani (3 out of 4 patents)

5.  Xing Li (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Viron Therapeutics, Inc.. Retrieved from https://idiyas.com/company/viron-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…